Grifols SA, Barcelona (NASDAQ:GRFS) Earns Media Impact Rating of 0.14

News coverage about Grifols SA, Barcelona (NASDAQ:GRFS) has been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Grifols SA, Barcelona earned a media sentiment score of 0.14 on Accern’s scale. Accern also gave media headlines about the biotechnology company an impact score of 46.436699633744 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Here are some of the news articles that may have effected Accern Sentiment Analysis’s rankings:

How to Become a New Pot Stock Millionaire

A number of equities analysts have weighed in on GRFS shares. BidaskClub cut shares of Grifols SA, Barcelona from a “hold” rating to a “sell” rating in a research report on Wednesday, February 28th. Morgan Stanley dropped their price objective on shares of Grifols SA, Barcelona from $23.00 to $22.00 and set an “underweight” rating for the company in a report on Thursday, March 1st. HSBC raised shares of Grifols SA, Barcelona from a “reduce” rating to a “hold” rating in a research note on Wednesday, March 14th. Zacks Investment Research raised shares of Grifols SA, Barcelona from a “sell” rating to a “hold” rating in a research note on Thursday, January 4th. Finally, ValuEngine raised shares of Grifols SA, Barcelona from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Three analysts have rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $22.50.

Shares of Grifols SA, Barcelona (GRFS) traded up $0.18 during trading hours on Thursday, reaching $21.20. 649,982 shares of the company traded hands, compared to its average volume of 599,293. The company has a current ratio of 3.01, a quick ratio of 1.35 and a debt-to-equity ratio of 1.62. Grifols SA, Barcelona has a 52-week low of $18.11 and a 52-week high of $25.18. The firm has a market capitalization of $13,868.13, a PE ratio of 19.27, a price-to-earnings-growth ratio of 1.29 and a beta of 1.18.

TRADEMARK VIOLATION NOTICE: “Grifols SA, Barcelona (NASDAQ:GRFS) Earns Media Impact Rating of 0.14” was first posted by BBNS and is the property of of BBNS. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of U.S. & international copyright legislation. The original version of this piece can be viewed at https://baseballnewssource.com/2018/03/29/grifols-sa-barcelona-grfs-receiving-somewhat-positive-media-coverage-analysis-finds/1970524.html.

About Grifols SA, Barcelona

Grifols, SA, a specialty pharmaceutical company, develops, manufactures, and distributes biological medicines on plasma derived proteins in the United States, Canada, Spain, rest of the European Union, and internationally. The company specializes in providing infusion solutions, nutrition products, and medical devices for use in hospitals and clinics.

Insider Buying and Selling by Quarter for Grifols SA, Barcelona (NASDAQ:GRFS)

Receive News & Ratings for Grifols SA Barcelona Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grifols SA Barcelona and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Bryce Harper Hits 406-Foot Home Run While Breaking His Bat
Bryce Harper Hits 406-Foot Home Run While Breaking His Bat
Rick Porcello’s Strong Start Gives Boost to Red Sox
Rick Porcello’s Strong Start Gives Boost to Red Sox
Two Bench Clearing Incidents Revive Red Sox-Yankees Rivalry
Two Bench Clearing Incidents Revive Red Sox-Yankees Rivalry
Xander Bogaerts Goes on Red Sox DL
Xander Bogaerts Goes on Red Sox DL
Ohtani Goes Deep in Third Straight Game for Angels
Ohtani Goes Deep in Third Straight Game for Angels
Charlie Blackmon Agrees to Contract Extension with Colorado Rockies
Charlie Blackmon Agrees to Contract Extension with Colorado Rockies


Leave a Reply

 
© 2006-2018 BBNS.